Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

215 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study.
Hensley MK, Bain WG, Jacobs J, Nambulli S, Parikh U, Cillo A, Staines B, Heaps A, Sobolewski MD, Rennick LJ, Macatangay BJC, Klamar-Blain C, Kitsios GD, Methé B, Somasundaram A, Bruno TC, Cardello C, Shan F, Workman C, Ray P, Ray A, Lee J, Sethi R, Schwarzmann WE, Ladinsky MS, Bjorkman PJ, Vignali DA, Duprex WP, Agha ME, Mellors JW, McCormick KD, Morris A, Haidar G. Hensley MK, et al. Among authors: vignali da. Clin Infect Dis. 2021 Aug 2;73(3):e815-e821. doi: 10.1093/cid/ciab072. Clin Infect Dis. 2021. PMID: 33507235 Free PMC article.
Epitope Mapping of Therapeutic Antibodies Targeting Human LAG3.
Agnihotri P, Mishra AK, Agarwal P, Vignali KM, Workman CJ, Vignali DAA, Mariuzza RA. Agnihotri P, et al. Among authors: vignali daa. J Immunol. 2022 Sep 14:ji2200309. doi: 10.4049/jimmunol.2200309. Online ahead of print. J Immunol. 2022. PMID: 36104110
Neuronally expressed PDL1, not PD1, suppresses acute nociception.
Meerschaert KA, Edwards BS, Epouhe AY, Jefferson B, Friedman R, Babyok OL, Moy JK, Kehinde F, Liu C, Workman CJ, Vignali DAA, Albers KM, Koerber HR, Gold MS, Davis BM, Scheff NN, Saloman JL. Meerschaert KA, et al. Among authors: vignali daa. Brain Behav Immun. 2022 Sep 8;106:233-246. doi: 10.1016/j.bbi.2022.09.001. Online ahead of print. Brain Behav Immun. 2022. PMID: 36089217
Therapeutic targeting of regulatory T cells in cancer.
Shan F, Somasundaram A, Bruno TC, Workman CJ, Vignali DAA. Shan F, et al. Among authors: vignali daa. Trends Cancer. 2022 Jul 16:S2405-8033(22)00136-4. doi: 10.1016/j.trecan.2022.06.008. Online ahead of print. Trends Cancer. 2022. PMID: 35853825 Review.
Antibodies targeting conserved non-canonical antigens and endemic coronaviruses associate with favorable outcomes in severe COVID-19.
Peddireddy SP, Rahman SA, Cillo AR, Vijay GM, Somasundaram A, Workman CJ, Bain W, McVerry BJ, Methe B, Lee JS, Ray P, Ray A, Bruno TC, Vignali DAA, Kitsios GD, Morris A, Singh H, Sarkar A, Das J. Peddireddy SP, et al. Among authors: vignali daa. Cell Rep. 2022 Jun 28;39(13):111020. doi: 10.1016/j.celrep.2022.111020. Epub 2022 Jun 13. Cell Rep. 2022. PMID: 35738278 Free PMC article.
215 results